Patent · US Active

BCMA chimeric antigen receptors

US12006369B2 · kind B2 · utility

2Cited by
42References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 18, 2019
Grant dateJun 11, 2024
Priority date—
Expiry dateApr 25, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/60
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.